Tarsus Pharmaceuticals, Inc.·4

Sep 10, 5:03 PM ET

LINK WILLIAM J PHD 4

4 · Tarsus Pharmaceuticals, Inc. · Filed Sep 10, 2025

Insider Transaction Report

Form 4
Period: 2025-09-08
Transactions
  • Sale

    Common Stock

    2025-09-08$57.00/sh27,116$1,545,612143,332 total
Holdings
  • Common Stock

    (indirect: By Link Family Enterprise, LP)
    10,446
Footnotes (2)
  • [F1]The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $56.66 to $57.45. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]The Reporting Person may be deemed to beneficially own the shares indirectly by reason of the Reporting Person as the controlling member of Link Family Enterprise, LP.

Documents

1 file
  • 4
    wk-form4_1757538213.xmlPrimary

    FORM 4